Canadian Rhinology Working Group consensus statement: biologic therapies for chronic rhinosinusitis

Recent evidence suggests that biologic therapy with targeted activity within the Type 2 inflammatory pathway can improve the clinical signs and symptoms of chronic rhinosinusitis with nasal polyposis (CRSwNP)....

Source: Journal of Otolaryngology - Head and Neck Surgery - March 9, 2021 Category: ENT & OMF Authors: Andrew Thamboo, S. Kilty, I. Witterick, Y. Chan, C. J. Chin, A. Janjua, A. Javer, J. Lee, E. Monterio, B. Rotenberg, J. Scott, K. Smith, D. D. Sommer, L. Sowerby, M. Tewfik, E. Wright & hellip; Tags: Original research article Source Type: research